Aurobindo Pharma Step-Down Subsidiary Subscribes to 100% Capital in A1 Biochem USA
Aurobindo Pharma Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 6:20 pm
Aurobindo Pharma Step-Down Subsidiary Subscribes to 100% Capital in A1 Biochem USA Aurobindo Pharma's step-down subsidiary, A1 Biochem Labs (India) Private Limited, subscribed to 10,000 equity shares of newly incorporated A1 Biochem USA Inc at USD 100 per share on 11th Sep'26, totaling a cash consideration of USD 1 mn. Following the subscription, A1 Biochem USA Inc is a 100% wholly owned subsidiary established to conduct Contract Research and Development (CRO/CDMO) services in the US. The transaction aligns with Aurobindo's earlier disclosed acquisition of the A1 Biochem Group on 23rd Jul'26.
Original exchange filing (PDF)
More announcements from Aurobindo Pharma Ltd
- Intimation of classification of US FDA inspection at Lannet Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. 路 12 Nov 2026
- Submission of Earning Call Transcript for Q2FY27. 路 11 Nov 2026
- Unit-2 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated". 路 11 Nov 2026
- Intimation of investors / analysts meet to be held on 17.11.2026. 路 09 Nov 2026
- Intimation of investor / analysts meet to be held on 16.09.2026. 路 09 Nov 2026
- Submission of Financial results for the Quarter and Half year ended September 30, 2026. 路 05 Nov 2026
- Reappointment of Mr. M. R. Kumar as Independent Director of the Company for second term with effect from April 1, 2027. 路 05 Nov 2026
- Transfer of ownership of Auro Pharma LLC, Russia from Auroactive Pharma Private Limited to Auropharm Overseas Limited, Wholly Owned subsidiaries of the Company. 路 05 Nov 2026
